QT
EPIX

Quantbot Technologies’s ESSA Pharma EPIX Stock Holding History

Quantbot Technologies’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,751
Closed -$4.41K – 1687
2022
Q4 		$4.41K Sell
1,751
-400
-19% -$1.15K ﹤0.01% 1563
2022
Q3 		$3K Buy
+2,151
New +$5.67K ﹤0.01% 1498
2022
Q2 		– Sell
-751
Closed -$4K – 1812
2022
Q1 		$4K Buy
+751
New +$6.6K ﹤0.01% 1547

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Quantbot Technologies's EPIX Position: Q1 2023 in Review

Quantbot Technologies sold out of ESSA Pharma (EPIX) in Q1 2023, closing a stake of 1,751 shares — an estimated $4.41K sold.

Quantbot Technologies first reported a position in EPIX in Q1 2022 and held it in 3 quarters. The position peaked at $4.41K in Q4 2022. 37 funds tracked by Wall St. Rank hold EPIX as of Q1 2023.

  • Quantbot Technologies reported no remaining ESSA Pharma position as of Q1 2023 after selling out during the quarter.
  • Quantbot Technologies sold 1,751 ESSA Pharma shares in Q1 2023, an estimated $4.41K.
  • Quantbot Technologies first reported a position in ESSA Pharma in Q1 2022 and held it in 3 quarters.
  • Quantbot Technologies's ESSA Pharma position peaked at $4.41K in Q4 2022.
  • 37 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2023.

Based on Quantbot Technologies's 13F filing for Q1 2023, filed 12 May 2023.